In vitro cytokine release from human peripheral blood mononuclear cells in the assessment of the immunotoxic potential of chemicals

Toxicology in Vitro

Volumn 25, Issue 2, 2011, Pages 555-562

  Stolevik S B ^a   Nygaard, U C ^a   Namork, E ^a   Granum, B ^a   Pellerud, A ^a   van Leeuwen, D M ^b   Gmuender, H ^c   van Delft, J H M ^b   van Loveren, H ^b   Lovik M ^a,d  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c GENEDATA AG   (Switzerland)

^d NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

Alternative methods; Cell proliferation; Cytokines; Immunotoxicity; In vitro; Peripheral blood mononuclear cells

Indexed keywords

2 AMINO 1 METHYL 6 PHENYLIMIDAZO[4,5 B]PYRIDINE; 2 AMINO 3 METHYLIMIDAZO[4,5 F]QUINOLINE; 2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; 4 HYDROXYNONENAL; AFLATOXIN B1; ALCOHOL; BENZO[A]PYRENE; CYTOKINE; DIMETHYLNITROSAMINE; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOTOXIN; INTERLEUKIN 10; INTERLEUKIN 11; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; INTERLEUKIN 9; MONOCYTE CHEMOTACTIC PROTEIN 1; POLYCHLORINATED BIPHENYL; VOMITOXIN;

ADULT; ARTICLE; BLOOD SAMPLING; CELL ISOLATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EXPOSURE; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOTOXICITY; IN VITRO STUDY; LIVER; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL;

ADULT; CELLS, CULTURED; CYTOKINES; FEMALE; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; PRINCIPAL COMPONENT ANALYSIS;

ANIMALIA;

EID: 79151482657     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tiv.2010.11.021     Document Type: Article

References (52)

1. Azcona-Olivera J.I., Ouyang Y., Murtha J., Chu F.S., Pestka J.J. Induction of cytokine mRNAs in mice after oral exposure to the trichothecene vomitoxin (deoxynivalenol): relationship to toxin distribution and protein synthesis inhibition. Toxicol. Appl. Pharmacol. 1995, 133:109-120.
2. Balls M., Goldberg A.M., Fentem J.H., Broadhead C.L., Burch R.L., Festing M.F., Frazier J.M., Hendriksen C.F., Jennings M., van der Kamp M.D., Morton D.B., Rowan A.N., Russell C., Russell W.M., Spielmann H., Stephens M.L., Stokes W.S., Straughan D.W., Yager J.D., Zurlo J., van Zutphen B.F. The three Rs: the way forward: the report and recommendations of ECVAM workshop 11. Altern. Lab. Anim. 1995, 23:838-866.
3. Baum M., Fauth E., Fritzen S., Herrmann A., Mertes P., Merz K., Rudolphi M., Zankl H., Eisenbrand G. Acrylamide and glycidamide: genotoxic effects in V79-cells and human blood. Mutat. Res. 2005, 580:61-69.
4. Belsley D.A., Kuh E., Welsh R.E. Regression Diagnostics Identifying Influential Data and Sources of Collinearity 1980, John Wiley and Sons, New York.
5. Carfi' M., Gennari A., Malerba I., Corsini E., Pallardy M., Pieters R., van Loveren H., Vohr H.W., Hartung T., Gribaldo L. In vitro tests to evaluate immunotoxicity: a preliminary study. Toxicology 2007, 229:11-22.
6. Coecke S., Ahr H., Blaauboer B.J., Bremer S., Casati S., Castell J., Combes R., Corvi R., Crespi C.L., Cunningham M.L., Elaut G., Eletti B., Freidig A., Gennari A., Ghersi-Egea J.F., Guillouzo A., Hartung T., Hoet P., Ingelman-Sundberg M., Munn S., Janssens W., Ladstetter B., Leahy D., Long A., Meneguz A., Monshouwer M., Morath S., Nagelkerke F., Pelkonen O., Ponti J., Prieto P., Richert L., Sabbioni E., Schaack B., Steiling W., Testai E., Vericat J.A., Worth A. Metabolism: a bottleneck in in vitro toxicological test development. The report and recommendations of ECVAM workshop 54. Altern. Lab. Anim. 2006, 34:49-84.
7. De Heer C., Verlaan A.P., Penninks A.H., Vos J.G., Schuurman H.J., van Loveren H. Time course of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced thymic atrophy in the Wistar rat. Toxicol. Appl. Pharmacol. 1994, 128:97-104.
8. De Jong W.H., van Loveren H. Screening of xenobiotics for direct immunotoxicity in an animal study. Methods 2007, 41:3-8.
9. De Jong W.H., Kroese E.D., Vos J.G., van Loveren H. Detection of immunotoxicity of benzo[a]pyrene in a subacute toxicity study after oral exposure in rats. Toxicol. Sci. 1999, 50:214-220.
10. European Commission, 2010. http://ec.europa.eu.
11. Galbiati V., Mitjans M., Corsini E. Present and future of in vitro immunotoxicology in drug development. J. Immunotoxicol. 2010, 7:255-267.
12. Gennari A., Ban M., Braun A., Casati S., Corsini E., Dastych J., Descotes J., Hartung T., Hooghe-Peters R., House R., Pallardy M., Pieters R., Reid L., Tryphonas H., Tschirhart E., Tuschl H., Vandebriel R., Gribaldo L. The use of in vitro systems for evaluating immunotoxicity: the report and recommendations of an ECVAM workshop. J. Immunotoxicol. 2005, 2:61-83.
13. Heilmann C., Grandjean P., Weihe P., Nielsen F., Budtz-Jorgensen E. Reduced antibody responses to vaccinations in children exposed to polychlorinated biphenyls. PLoS Med. 2006, 3:e311.
14. Hinton D.M., Myers M.J., Raybourne R.A., Francke-Carroll S., Sotomayor R.E., Shaddock J., Warbritton A., Chou M.W. Immunotoxicity of aflatoxin B1 in rats: effects on lymphocytes and the inflammatory response in a chronic intermittent dosing study. Toxicol. Sci. 2003, 73:362-377.
15. Hochstenbach K., van Leeuwen D.M., Gmuender H., Stolevik S.B., Nygaard U.C., Lovik M., Granum B., Namork E., van Delft J.H., van L.H. Transcriptomic profile indicative of immunotoxic exposure: in vitro studies in peripheral blood mononuclear cells. Toxicol. Sci. 2010, 118:19-30.
16. Holsapple M.P., Snyder N.K., Wood S.C., Morris D.L. A review of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced changes in immunocompetence: 1991 update. Toxicology 1991, 69:219-255.
17. House R.V. Theory and practice of cytokine assessment in immunotoxicology. Methods 1999, 19:17-27.
18. Hymery N., Sibiril Y., Parent-Massin D. Improvement of human dendritic cell culture for immunotoxicological investigations. Cell Biol. Toxicol. 2006, 22:243-255.
19. Instanes C., Hetland G. Deoxynivalenol (DON) is toxic to human colonic, lung and monocytic cell lines, but does not increase the IgE response in a mouse model for allergy. Toxicology 2004, 204:13-21.
20. Ito T., Inouye K., Fujimaki H., Tohyama C., Nohara K. Mechanism of TCDD-induced suppression of antibody production: effect on T cell-derived cytokine production in the primary immune reaction of mice. Toxicol. Sci. 2002, 70:46-54.
21. Kerkvliet N.I. Recent advances in understanding the mechanisms of TCDD immunotoxicity. Int. Immunopharmacol. 2002, 2:277-291.
22. Kim Y.S., Park Z.Y., Kim S.Y., Jeong E., Lee J.Y. Alteration of Toll-like receptor 4 activation by 4-hydroxy-2-nonenal mediated by the suppression of receptor homodimerization. Chem. Biol. Interact. 2009, 182:59-66.
23. Koeper L.M., Vohr H.W. Functional assays are mandatory for a correct prediction of immunotoxic properties of compounds in vitro. Food Chem. Toxicol. 2009, 47:110-118.
24. Kooijman R., Devos S., Hooghe-Peters E. Inhibition of in vitro cytokine production by human peripheral blood mononuclear cells treated with xenobiotics: implications for the prediction of general toxicity and immunotoxicity. Toxicol. In Vitro 2010, 24:1782-1789.
25. Ladics G.S., White K.L. Immunotoxicity of polyaromatic hydrocarbons. Experimental Immunotoxicology 1996, 331-349. CRC Press Inc., USA. R.J. Smialowicz, M.P. Holsapple (Eds.).
26. Langezaal I., Coecke S., Hartung T. Whole blood cytokine response as a measure of immunotoxicity. Toxicol. In Vitro 2001, 15:313-318.
27. Lankveld D.P., van Loveren H., Baken K.A., Vandebriel R.J. In vitro testing for direct immunotoxicity: state of the art. Methods Mol. Biol. 2010, 598:401-423.
28. Lebrec H., Roger R., Blot C., Burleson G.R., Bohuon C., Pallardy M. Immunotoxicological investigation using pharmaceutical drugs. In vitro evaluation of immune effects using rodent or human immune cells. Toxicology 1995, 96:147-156.
29. Levin M., Leibrecht H., Ryan J., van Dolah F., De G.S. Immunomodulatory effects of domoic acid differ between in vivo and in vitro exposure in mice. Mar. Drugs 2008, 6:636-659.
30. Lyche J., Larsen H., Skaare J.U., Tverdal A., Dahl E., Johansen G., Ropstad E. Effects of perinatal exposure to low doses of PCB 153 and PCB 126 on lymphocyte proliferation and hematology in goat kids. J. Toxicol. Environ. Health A 2004, 67:889-904.
31. Marin D.E., Taranu I., Bunaciu R.P., Pascale F., Tudor D.S., Avram N., Sarca M., Cureu I., Criste R.D., Suta V., Oswald I.P. Changes in performance, blood parameters, humoral and cellular immune responses in weanling piglets exposed to low doses of aflatoxin. J. Anim. Sci. 2002, 80:1250-1257.
32. Meissonnier G.M., Pinton P., Laffitte J., Cossalter A.M., Gong Y.Y., Wild C.P., Bertin G., Galtier P., Oswald I.P. Immunotoxicity of aflatoxin B1: impairment of the cell-mediated response to vaccine antigen and modulation of cytokine expression. Toxicol. Appl. Pharmacol. 2008, 231:142-149.
33. Meky F.A., Hardie L.J., Evans S.W., Wild C.P. Deoxynivalenol-induced immunomodulation of human lymphocyte proliferation and cytokine production. Food Chem. Toxicol. 2001, 39:827-836.
34. Merlo D.F., Wild C.P., Kogevinas M., Kyrtopoulos S., Kleinjans J. NewGeneris: a European study on maternal diet during pregnancy and child health. Cancer Epidemiol. Biomarkers Prev. 2009, 18:5-10.
35. Murphy K., Travers P., Walport M. Janeway's Immunobiology 2008, Garland Science, Taylor and Francis Group, LLC.
36. Nohara K., Fujimaki H., Tsukumo S., Inouye K., Sone H., Tohyama C. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on T cell-derived cytokine production in ovalbumin (OVA)-immunized C57Bl/6 mice. Toxicology 2002, 172:49-58.
37. Oppenheim, J.J., Feldmann, M., Durum, S.K., Hirano, T., Vilcek, J., Nicola, N.A., 2001. Cytokine Reference. Academic Press.
38. Ouyang Y.L., Azcona-Olivera J.I., Murtha J., Pestka J.J. Vomitoxin-mediated IL-2, IL-4, and IL-5 superinduction in murine CD4+ T cells stimulated with phorbol ester calcium ionophore: relation to kinetics of proliferation. Toxicol. Appl. Pharmacol. 1996, 138:324-334.
39. Pinton P., Accensi F., Beauchamp E., Cossalter A.M., Callu P., Grosjean F., Oswald I.P. Ingestion of deoxynivalenol (DON) contaminated feed alters the pig vaccinal immune responses. Toxicol. Lett. 2008, 177:215-222.
40. Quintana F.J., Basso A.S., Iglesias A.H., Korn T., Farez M.F., Bettelli E., Caccamo M., Oukka M., Weiner H.L. Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor. Nature 2008, 453:65-71.
41. Ringerike T., Ulleras E., Volker R., Verlaan B., Eikeset A., Trzaska D., Adamczewska V., Olszewski M., Walczak-Drzewiecka A., Arkusz J., van Loveren H., Nilsson G., Lovik M., Dastych J., Vandebriel R.J. Detection of immunotoxicity using T-cell based cytokine reporter cell lines (" Cell Chip"). Toxicology 2005, 206:257-272.
42. Robbana-Barnat S., Lafarge-Frayssinet C., Cohen H., Neish G.A., Frayssinet C. Immunosuppressive properties of deoxynivalenol. Toxicology 1988, 48:155-166.
43. Rotter B.A., Prelusky D.B., Pestka J.J. Toxicology of deoxynivalenol (vomitoxin). J. Toxicol. Environ. Health 1996, 48:1-34.
44. Smialowicz R.J., DeVito M.J., Riddle M.M., Williams W.C., Birnbaum L.S. Opposite effects of 2,2',4,4',5,5'-hexachlorobiphenyl and 2,3,7,8-tetrachlorodibenzo-p-dioxin on the antibody response to sheep erythrocytes in mice. Fundam. Appl. Toxicol. 1997, 37:141-149.
45. Szabo G. Alcohol's contribution to compromised immunity. Alcohol. Health Res. World 1997, 21:30-41.
46. Szabo G., Mandrekar P. A recent perspective on alcohol, immunity, and host defense. Alcohol. Clin. Exp. Res. 2009, 33:220-232.
47. Tryphonas H., Iverson F., So Y., Nera E.A., McGuire P.F., O'Grady L., Clayson D.B., Scott P.M. Effects of deoxynivalenol (vomitoxin) on the humoral and cellular immunity of mice. Toxicol. Lett. 1986, 30:137-150.
48. Tuma D.J. Role of malondialdehyde-acetaldehyde adducts in liver injury. Free Radic. Biol. Med. 2002, 32:303-308.
49. van Leeuwen D.M., Gottschalk R.W., van Herwijnen M.H., Moonen E.J., Kleinjans J.C., van Delft J.H. Differential gene expression in human peripheral blood mononuclear cells induced by cigarette smoke and its constituents. Toxicol. Sci. 2005, 86:200-210.
50. Wagner W., Walczak-Drzewiecka A., Slusarczyk A., Biecek P., Rychlewski L., Dastych J. Fluorescent cell chip a new in vitro approach for immunotoxicity screening. Toxicol. Lett. 2006, 162:55-70.
51. Wang G., Konig R., Ansari G.A., Khan M.F. Lipid peroxidation-derived aldehyde-protein adducts contribute to trichloroethene-mediated autoimmunity via activation of CD4+ T cells. Free Radic. Biol. Med. 2008, 44:1475-1482.
52. Weisglas-Kuperus N., Patandin S., Berbers G.A., Sas T.C., Mulder P.G., Sauer P.J., Hooijkaas H. Immunologic effects of background exposure to polychlorinated biphenyls and dioxins in Dutch preschool children. Environ. Health Perspect. 2000, 108:1203-1207.